Creating Strong Patents in Europe
A recent Board of Appeal decision at the European Patent Office has potentially far-reaching implications for the fields of biotechnology and pharmaceuticals. What impact has this decision had and should patent-filing strategies be altered in view of the developing case law?
By Allie Elend and Stephen Johnson at Venner Shipley LLP (March 2009)
Keywords: New Developments, Consequences to date, strategic implications